FDA Pushes Enrollment of Underrepresented Populations in Clinical Trials with Recent ‘Race and Ethnicity Diversity Plan' Draft Guidance May 5, 2022
CMS Issues New No Surprises Act FAQS on Good Faith Estimates and the Overall Requirements and Exceptions for Healthcare Providers April 14, 2022
Update on Act 444 as it Relates to Nurse Practitioners Authority to Recommend Medical Marijuana April 1, 2022
